Skip to content

Effect of Qiwei Baizhu San on glucose and lipid metabolism and distribution of intestinal flora in obesity patients with spleen deficiency and dampness retention

Effect of Qiwei Baizhu San on glucose and lipid metabolism and distribution of intestinal flora in obesity patients with spleen deficiency and dampness retention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014875
Enrollment
Unknown
Registered
2018-02-12
Start date
2018-02-20
Completion date
Unknown
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Treatment group: Qiweibaizhu san
Control group:none

Sponsors

Wuxi Hospital of Chinese Medicine (Wuxi Hospital Affiliated to Nanjing University of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of obesity patients with spleen deficiency and dampness retentionin; 2. Aged 18-65 years old male and female; 3. Did not accept any treatment to loss weight except for dietary and exercise 3 months before treatment; 4. Did not use antibiotics or probiotics 1 months before treatment; 5. No gastrointestinal disease or liver and biliary tract infection history; 6. Participate voluntarily and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Secondary obesity, like hypothalamic disease, pituitary disease, pancreatic islet dysfunction and hypothyroidism; 2. Used drugs that affect glucose metabolism and insulin secretion; 3. Patients with serious heart, brain, liver or kidney disease; 4. Patients with tumor, immune system or hematological disease; 5. Mental illness patients; 6. Pregnant or lactating women; 7. Insufficient understanding of the study, unwilling participants or poor compliance.

Design outcomes

Primary

MeasureTime frame
blood glucose;blood lipid;insulin;HbA1c;distribution of intestinal flora;endotoxin;

Countries

China

Contacts

Public ContactLu Xiwan

Wuxi Hospital of Chinese Medicine(Wuxi Hospital Affiliated to Nanjing University of Chinese Medicine)

lu_xiwan@sohu.com+86 13806189543

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026